openPR Logo
Press release

Calciphylaxis Treatment Market Report 2018-2026 Focuses On Top Companies 3M, Amgen , BSN Medical, ConvaTec , Medtronic , Smith & Nephew

Calciphylaxis Treatment

Calciphylaxis Treatment

The global calciphylaxis treatment market size was valued at US$ 1,097.7 million in 2017 and is expected to witness a CAGR of 9.6% over the forecast period (2018 – 2026).

Calciphylaxis or Calcific Uremic Arteriolopathy (CUA) is the most severe form of cardiovascular calcification in dialysis patients. It starts with a calcification of small peripheral vessels and quickly spreads in the body. Moreover, people suffering from calciphylaxis have an imbalance in calcium metabolism, which causes calcium to be deposited in arterioles, which eventually leads to the formation of blood clots in the arterioles. Blood clots can cause fat tissues and skin to be deprived of oxygen and nourishment.

According to a data published by National Center for Biotechnology Information (NCBI) 2014 report, calciphylaxis affects around 4% of patients in the late stage of chronic kidney disease and 55% of patients with calciphylaxis die within a year of diagnosis and suffer from painful skin ulcers and a high risk of infection. No effective treatment for calciphylaxis is currently available and its causes are unknown. However, patients suffering from this disease are usually treated with intensive care, including wound management. The occurrence of calciphylaxis is associated with hyperthyroidism.

According to the Journal of General Internal Medicine 2014 study, calciphylaxis has an increasing incidence trend and a 50% mortality rate within the first year of onset. High prevalence of kidney disease is a major factor for incidences of calciphylaxis. According to the National Institute of Diabetes and Digestive and Kidney Diseases Health Information Center, in 2016, over 661,000 Americans had kidney failure and 468,000 of these patients were on dialysis.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/2251

Various academic research institutes and companies are focused on developing suitable treatment for calciphylaxis. For instance in March 2018, Sanifit successfully completed a Phase II trial of the first effective treatment for calciphylaxis. Moreover, in 2014, researchers at the National Kidney Foundation reported successful application of intravenous (IV) pamidronate to treat calciphylaxis in patients with End-Stage Renal Disease (ESRD).

Calciphylaxis Treatment Market Restraints

Lack of an appropriate treatment for calciphylaxis is a major factor hindering growth of the global calciphylaxis treatment market. However, increasing research to develop a suitable treatment for the condition is expected to drive growth of the market.

Calciphylaxis Treatment Market - Regional Insights

On the basis of region, the global calciphylaxis treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America calciphylaxis treatment market is expected to foresee major revenue share, owing to increasing government support and funding to treat calciphylaxis patients. According to the National Kidney Disease Education Program study 2015, in the U.S., treatment of chronic kidney disease surpasses US$ 48 billion, annually and the ESRD program consumes 6.7% of the total Medicare budget to care for less than 1% of the covered population.

Asia Pacific calciphylaxis treatment market is expected to witness growth at a significant CAGR, owing to increasing expenditure in treatment of kidney diseases coupled with high prevalence of kidney diseases with diabetes and growing geriatric population base. For instance, according to the National Kidney Disease Education Program study 2015, in Australia, treatment for all current and new cases of kidney failure by 2020 is expected to cost around US$ 12 billion. Moreover, annual cost of dialysis per patient, annually varies between US $35,000 and 55,000 depending on the type of treatment.

Get Discount On This Report:
https://www.coherentmarketinsights.com/insight/request-discount/2251

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Calciphylaxis Treatment Market Report 2018-2026 Focuses On Top Companies 3M, Amgen , BSN Medical, ConvaTec , Medtronic , Smith & Nephew here

News-ID: 1493569 • Views: 244

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases


More Releases for Calciphylaxis

Calciphylaxis Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Calciphylaxis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Calciphylaxis, historical and forecasted epidemiology as well as the Calciphylaxis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Calciphylaxis market report provides current treatment practices, emerging drugs, Calciphylaxis market share of the individual therapies, and current and forecasted Calciphylaxis market size from 2019 to 2032 segmented by
Comprehensive Analysis of Calciphylaxis Treatment Market From 2018-2028 | Labora …
Global Calciphylaxis Treatment Market: Overview The rising prevalence of calcific uremic arteriolopathy (CUA) in patients with renal failure, this can be important factor influencing demand for the global calciphylaxis treatment market. This condition is also recognized in the patient diagnosed with the non-uremic patients. This can be another key reason for the market growth at global level. Get Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=4239 The global market for calciphylaxis treatment can be
Calciphylaxis Treatment Market – Product Modifications Overview 2028 | Laborat …
Global Calciphylaxis Treatment Market: Overview The rising prevalence of calcific uremic arteriolopathy (CUA) in patients with renal failure, this can be important factor influencing demand for the global calciphylaxis treatment market. This condition is also recognized in the patient diagnosed with the non-uremic patients. This can be another key reason for the market growth at global level. Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=4239 The global market for calciphylaxis treatment can be
Calciphylaxis Market 2017-2023 | Amgen Inc., Smith & Nephew plc, Medtronics, 3M, …
Market Research Future has a cooked research report on the Global Calciphylaxis Market. The Global Calciphylaxis Market is expected to grow at a CAGR of 10.70% during the forecast period 2017-2023. Major Players in the Calciphylaxis Market: Some of the key players in this market are Amgen Inc., Smith & Nephew plc, Medtronics, 3M, BSN Medical, ConvaTec Inc, Sanifit, and others. Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/3567 Market Highlights: A number options are available in the market
Calciphylaxis Treatment Market Report: Global Industry Assesmenent and Forcast t …
Calciphylaxis, also known as calcific uremic arteriolopathy (CUA), is a rare condition characterized by calcification or the aggregation of calcium in a patient’s blood vessels and the development of thrombosis. This can lead to the death of cells in a patient’s skin and fatty tissues, thereby causing death. It is seen mostly in people with end-stage kidney disease but can occur in the earlier stages of chronic kidney disease and
Calciphylaxis Market Segments, Key Players Strategies, Analysis and Forecasts Ti …
The Global Calciphylaxis Market report titled “Calciphylaxis Market Research Report-Forecast to 2023″ is a specialist investigation report by Market Research Future includes broad essential research alongside the definite examination of subjective and additionally quantitative perspectives by different industry specialists, key sentiment pioneers to pick up a more profound understanding of the market and industry execution. Considering all these factors The World Calciphylaxis Market research report was around US$ 2250.0 million